IL-6/STAT3 Signaling Contributes to Sorafenib Resistance in Hepatocellular Carcinoma Through Targeting Cancer Stem Cells [Corrigendum]
Li Y, Chen G, Han Z, Cheng H, Qiao L, Li Y. Onco Targets Ther. 2020;13:9721–9730. The authors have advised due to an error at the time of figure assembly, Figure 4 on page 9728 is incorrect. The correct Figure 4 is shown below. The authors apologize for this erro...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2020-11-01
|
| Series: | OncoTargets and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/corrigendum-il-6stat3-signaling-contributes-to-sorafenib-resistance-in-peer-reviewed-article-OTT |